Corbus Pharmaceuticals Holdings, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Corbus Pharmaceuticals Holdings, Inc. (CRBP) is 78.70M

According to Corbus Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 78.70M. This represents a change of -17.02% compared to the average of 94.84M of the last 4 quarters.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Historical Enterprise Value (quarterly & annually)

How has CRBP Enterprise Value performed in the past?

The mean historical Enterprise Value of Corbus Pharmaceuticals Holdings, Inc. over the last ten years is 161.31M. The current 78.70M Enterprise Value has changed 4.78% with respect to the historical average. Over the past ten years (40 quarters), CRBP's Enterprise Value was at its highest in in the June 2020 quarter at 565.02M. The Enterprise Value was at its lowest in in the December 2022 quarter at 21.98M.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Corbus Pharmaceuticals Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Average Enterprise Value

How has CRBP Enterprise Value performed in the past?

The current Enterprise Value of Corbus Pharmaceuticals Holdings, Inc. (CRBP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Enterprise Value vs. Peers

How is CRBP’s Enterprise Value compared to its peers?

Corbus Pharmaceuticals Holdings, Inc.’s Enterprise Value is greater than Applied Therapeutics, Inc. (5.42M), greater than Elicio Therapeutics, Inc. (72.87M), greater than Molecular Partners AG (40.49M), greater than Cardiff Oncology, Inc. (74.83M), greater than Rani Therapeutics Holdings, Inc. (45.40M), less than Milestone Pharmaceuticals Inc. (177.67M), less than Forte Biosciences, Inc. (189.64M), less than PepGen Inc. (98.22M), less than Innate Pharma S.A. (145.48M), less than Alector, Inc. (151.88M),

Build a custom stock screener for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corbus Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corbus Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.